Literature DB >> 9331192

A prospective evaluation of alcohol-assisted versus mechanical epithelial removal before photorefractive keratectomy.

J C Abad1, B An, W J Power, C S Foster, D T Azar, J H Talamo.   

Abstract

OBJECTIVE: The purpose of the study is to compare alcohol-assisted versus mechanical debridement of the corneal epithelium before photorefractive keratectomy (PRK) for low-to-moderate myopia.
DESIGN: A prospective study was performed on a group of consecutive patients operated on at the Massachusetts Eye and Ear Infirmary from February to April 1996 and followed for 6 months. PARTICIPANTS: Eighty patients (eyes) were divided in 2 groups: 40 alcohol and 40 mechanical. INTERVENTION: The patients underwent PRK for myopia (-1.5 to -7.5 diopters) with a Summit Apex excimer laser. The corneal epithelium was removed either with 20% ethanol or with a scalpel blade. MAIN OUTCOME MEASURES: The two groups were compared for epithelial removal time, epithelial defect size at the end of surgery, and rate of re-epithelialization. Uncorrected visual acuity (UCVA), refractive outcome, best-corrected visual acuity (BCVA), and subjective haze were measured at 4 days and at 1, 3, and 6 months. In an additional short-term study, 40 patients (20 alcohol, 20 mechanical) had intraoperative pachymetry performed.
RESULTS: Alcohol-assisted de-epithelialization was faster than mechanical debridement (107 [+/-20.6 standard deviation] versus 141 [+/-30.5] seconds [P < 0.0001]) and led to a more circumscribed and reproducible epithelial defect at the end of surgery (87,739 [+/-11,852] versus 103,518 [+/-33,942] square pixels [t test, P = 0.04; f test, P = 0.001]). At 4 days, 95% of the alcohol-treated patients had healed compared with 78% of the mechanically scraped patients (Fisher's exact test, P = 0.04). The alcohol group had a better UCVA at 4 days (logarithm of the minimum angle of resolution UCVA 0.36 [+/-0.22] versus 0.51 [+/-0.26]) and at 1 month (0.14 [+/-0.17] versus 0.22 [+/-0.16] [Mann-Whitney U test, P = 0.02 and P = 0.03]) but equalized at 3 months (0.10 [+/-0.14] versus 0.13 [+/-0.16]) and at 6 months (0.11 [+/-0.15] versus 0.14 [+/-0.13] [Mann-Whitney U test, P = 0.23 and P = 0.34]). There was a trend toward less subjective haze in the alcohol-treated patients over the course of the study (area under the curve, 71.9 [+/-35.3] versus 87.9 [+/-33.8] [Mann-Whitney U test, P = 0.07]). The difference from target was equivalent in both groups at 6 months (-0.22 [+/-0.58] diopter in the alcohol group and -0.43 [+/-0.52] diopter in the mechanical group [t test, P = 0.14; f test, P = 0.57]). There were no differences in intraoperative pachymetry, corneal uniformity index as calculated from the corneal topography, and loss of BCVA between the two groups.
CONCLUSIONS: Twenty percent ethanol is a simple, safe, and effective alternative to mechanical scraping before PRK and appears to be associated with a quicker visual rehabilitation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9331192     DOI: 10.1016/s0161-6420(97)30095-5

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  12 in total

1.  Coenzyme Q10 rescues ethanol-induced corneal fibroblast apoptosis through the inhibition of caspase-2 activation.

Authors:  Chun-Chen Chen; Shiow-Wen Liou; Chi-Chih Chen; Wen-Chung Chen; Fung-Rong Hu; I-Jong Wang; Shing-Jong Lin
Journal:  J Biol Chem       Date:  2013-02-19       Impact factor: 5.157

2.  Spectral OCT with speckle contrast reduction for evaluation of the healing process after PRK and transepithelial PRK.

Authors:  Bartlomiej J Kaluzny; Maciej Szkulmowski; Danuta M Bukowska; Maciej Wojtkowski
Journal:  Biomed Opt Express       Date:  2014-03-05       Impact factor: 3.732

3.  Comparison of visual and refractive results after transepithelial and mechanical photorefractive keratectomy in myopia.

Authors:  Yusuf Yildirim; Onur Olcucu; Nese Alagoz; Alper Agca; Yalcin Karakucuk; Ahmet Demirok
Journal:  Int Ophthalmol       Date:  2017-03-27       Impact factor: 2.031

4.  Long term results of no-alcohol laser epithelial keratomileusis and photorefractive keratectomy for myopia.

Authors:  Leopoldo Spadea; Francesca Verboschi; Vittoria De Rosa; Mariella Salomone; Enzo Maria Vingolo
Journal:  Int J Ophthalmol       Date:  2015-06-18       Impact factor: 1.779

5.  Coenzyme Q10 reduces ethanol-induced apoptosis in corneal fibroblasts.

Authors:  Chun-Chen Chen; Shiow-Wen Liou; Chi-Chih Chen; Wen-Chung Chen; Fung-Rong Hu; I-Jong Wang; Shing-Jong Lin
Journal:  PLoS One       Date:  2011-04-27       Impact factor: 3.240

6.  Alcohol-assisted versus Mechanical Epithelium Removal in Photorefractive Keratectomy.

Authors:  Mohammad Ghoreishi; Hossein Attarzadeh; Mehdi Tavakoli; Heidar Ali Moini; Alireza Zandi; Amin Masjedi; Akram Rismanchian
Journal:  J Ophthalmic Vis Res       Date:  2010-10

7.  Comparison between Transepithelial Photorefractive Keratectomy versus Alcohol-Assisted Photorefractive Keratectomy in Correction of Myopia and Myopic Astigmatism.

Authors:  Ashraf M Bakhsh; Shaaban A M Elwan; Ahsan A Chaudhry; Tamer M El-Atris; Taghleb M Al-Howish
Journal:  J Ophthalmol       Date:  2018-11-12       Impact factor: 1.909

8.  Single-Step Transepithelial PRK vs Alcohol-Assisted PRK in Myopia and Compound Myopic Astigmatism Correction.

Authors:  Bartlomiej J Kaluzny; Iwona Cieslinska; Samuel A Mosquera; Shwetabh Verma
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.817

9.  Cyclodextrin Enhances Corneal Tolerability and Reduces Ocular Toxicity Caused by Diclofenac.

Authors:  Hamdy Abdelkader; Zeinab Fathalla; Hossam Moharram; Taha F S Ali; Barbara Pierscionek
Journal:  Oxid Med Cell Longev       Date:  2018-02-13       Impact factor: 6.543

10.  Comparison of ocular discomfort after three different epithelial debridement techniques for corneal collagen cross-linking in keratoconus treatment.

Authors:  Hosamadden Alkayid; Leyla Asena; Aslihan Yüce; Meriç Yavuz Çolak; Dilek Dursun Altınörs
Journal:  Ther Adv Ophthalmol       Date:  2021-06-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.